Necessity of Aspiration in the Ventrogluteal Site

Study Overview
=================
Brief Summary
-----------------
H1: Aspiration is not necessary for IM injections applied from the ventrogluteal region. H2: Aspiration procedure increases pain in IM injections applied from ventrogluteal region. H3: The duration of the aspiration procedure on IM injections applied from the ventrogluteal region is effective on pain.

Official Title
-----------------
Investigation of the Necessity of Aspiration During The Intramuscular Injection Administered in the Ventrogluteal Site and Its Effect on Pain

Conditions
-----------------
Nursing, Injection Site

Intervention / Treatment
-----------------
* Other: The Necessity of Aspiration


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient who came to the Emergency Service Care Unit for Diclofenac Sodium injection Have no vision and hearing problems, Who have no disease that may affect their perception of pain Who can evaluate the Visual Analog Scale correctly, scoring 5 points or less from the VAS, Body Mass Index is between 18.5-24.9 kg / m2, Who do not have any discomfort in the extremities that will prevent them from taking the desired position, No complications due to intramuscular injections such as abscess, infection, tissue necrosis and hematoma in the ventrogluteal region No nodules or masses in the area Exclusion Criteria: Patients who refuse the injection are excluded.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Experimental Group A<br>Experimental Group A who were administered intramuscular injection during which aspiration lasted for 5-10 seconds. | Other: The Necessity of Aspiration<br>* The patients who met the inclusion criteria and agreed to participate in the study were assigned to the Experimental Group A who were administered IM injection during which aspiration lasted for 5-10 seconds, to the Control Group who were administered IM injection during which aspiration lasted for 1-2 seconds, and to the Experimental Group B who were not administered IM injection according to the stratified block randomization list. The same Intramuscular Injection Application Protocol was applied while all the injections were administered.<br>|
| No Intervention: Control Group<br>Control Group who were administered intramuscular injection during which aspiration lasted for 1-2 seconds. | |
| Experimental: Experimental Group B<br>Experimental Group B who were not administered aspiration during IM injection. | Other: The Necessity of Aspiration<br>* The patients who met the inclusion criteria and agreed to participate in the study were assigned to the Experimental Group A who were administered IM injection during which aspiration lasted for 5-10 seconds, to the Control Group who were administered IM injection during which aspiration lasted for 1-2 seconds, and to the Experimental Group B who were not administered IM injection according to the stratified block randomization list. The same Intramuscular Injection Application Protocol was applied while all the injections were administered.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Individual Introductory Information Form | The content of the study was explained to the patients coming to the emergency room. Written informed consents were obtained in line with the Individual Introductory Information Form of the patients. Individual Introductory Information Form: This form includes questions such as the patient's application group, diagnosis, age, gender, height, weight, and blood intake during aspiration in intramuscular injection. It is completed within the first 10-15 minutes of contact with the patient. | 15 minutes | 
| Visual Analog Scale (VAS) | Intramuscular injection was performed in accordance with the application group assigned to the patients who filled the Individual Introductory Information Form. The patients were not told which group they belonged to. A nurse who except the researcher who performed the application evaluated pain levels that patients feel during injection immediately after the intramuscular injection application, with a Visual Analog Scale. The minimum score that can be obtained from this scale is 0 and the maximum score is 10. A higher score indicates that the pain is more severe. This scale was applied in minutes 1-5 after intramuscular injection. | 5 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Ventrogluteal area, aspiration